The Lancet Gastroenterology & Hepatology in conversation with

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

The Lancet Gastroenterology & Hepatology in conversation with is a health podcast hosted by Unknown Host, with 49 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts The Lancet Gastroenterology & Hepatology in conversation with, a health show with 49 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  The Lancet Gastroenterology & Hepatology in conversation with

  Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease

  Feb 23, 202620 minS0

  <p>Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of recent drinking, showing substantial underestimation and potential reclassification from MASLD to MetALD/ALD.</p> <p>Click here to read the full article:</p> <p><b>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext</b></p> <p>Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch...

  ListenShow Notes
• 

  The Lancet Gastroenterology & Hepatology in conversation with

  Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection

  Nov 28, 202516 minS0

  <p>Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies.</p> <p>Click here to read the full article: <b>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext</b></p> <p>Continue this conversation on social!</p> <p>Follow us today at...</p> <p>https://bsky.app/profile/lancetgastrohep.bsky.social</p> <p>https://www.linkedin.com...

  ListenShow Notes
• 

  The Lancet Gastroenterology & Hepatology in conversation with

  Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS

  Nov 20, 202516 minS0

  <p>Do wheat or gluten trigger IBS symptoms? </p> <p>We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses.</p> <p>Click here to read the full article: <b>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext</b></p> <p>Continue this conversation on social!</p> <p>Follow us today at...</p> <p>https://bsky.app/profile/lancetgastrohep.bsky.social</p> <p>https://www.linkedin.com/company/langastro/</p> <p>htt...

  ListenShow Notes
• 

  The Lancet Gastroenterology & Hepatology in conversation with

  Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma

  Jun 19, 202527 minS0

  <p>Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.</p> <p>Read the full article:</p> <p>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas</p> <p>Continue this conversation on social!</p> <p>Follow us today at...</p> <p>https://bsky.app/profile/lancetgastrohep.bsky.social</p> <p>https://www.linkedin.com/company/langastro/</p> <p>https...

  ListenShow Notes
• 

  The Lancet Gastroenterology & Hepatology in conversation with

  Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis

  Apr 9, 202519 minS0

  <p>How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis? </p> <p>We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents.</p> <p>Read the full article:</p> <p>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</p> <p>Continue this conversation on social!</p> <p>Follow us today at...</p> <p>https://bsky.app/profile/lancetgastrohep.bsky.social</p> <p>https://www.l...

  ListenShow Notes

Recent guests on The Lancet Gastroenterology & Hepatology in conversation with. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.